Evaluation of the association of autoantibodies with mortality in the very elderly: a cohort study

John P A Ioannidis; Gikas Katsifis; Efthymios Stavropoulos; M. N. Manoussakis; Haralampos Μ. Moutsopoulos

doi:10.1093/rheumatology/keg096

Abstract

1 min read

Our results exclude the possibility that the autoantibodies evaluated increase substantially the risk of death among very elderly subjects in good functional condition.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2020

Oral anticoagulants in extremely high risk very elderly (&gt;90 years) patients with Atrial Fibrillation

Tze‐Fan Chao, Professor Gregory Lip, S.A Chen

Article2007

Autoantibodies against endothelial protein C receptor and the risk of a first deep vein thrombosis

Astrid van Hylckama Vlieg, Ramón Montes, Frits R. Rosendaal, José Hermida

Journal of Thrombosis and Haemostasis

Article2025

Direct oral anticoagulants in very elderly and high-bleeding-risk patients with atrial fibrillation often excluded from oral anticoagulation therapy: a nationwide population-based cohort study.

Y. Go, So-Ryoung Lee, Hyo‐Jeong Ahn, Kyungdo Han, Seil Oh, Professor Gregory Lip

Article2025

ASSOCIATION OF ORTHOSTATIC BP CHANGES WITH ECHOCARDIOGRAPHIC VARIABLES IN ELDERLY HYPERTENSIVE PATIENTS

Alessandro Croce, Grzegorz Bilo, Martino F. Pengo, Antonella Zambon, Davide Soranna, Alice Margherita Ornago, María Cristina Ferrara, Alice Riccò, Giuseppe Bellelli, Gianfranco Parati

Letter2018

Response by Chao et al to Letter Regarding Article, “Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study”

Tze‐Fan Chao, Professor Gregory Lip, Shih‐Ann Chen